Navigation Links
One-Third of Schools Built in Air Pollution Danger Zones
Date:8/25/2008

Unhealthy proximity to major roads is public health concern future planners should address

MONDAY, Aug. 25 (HealthDay News) -- More than 30 percent of U.S. public schools are within a quarter mile of major highways, which puts them in the "air pollution danger zone," says a University of Cincinnati study.

Previous research has shown that proximity to major highways and pollutants spewed by vehicles can increase school children's susceptibility to respiratory diseases later in life.

In this new study, the researchers examined data on more than 8,000 schools with 6 million students in Atlanta, Boston, Cincinnati, Denver, Philadelphia, Los Angeles, Memphis, Minneapolis and San Antonio.

"This is a major public health concern that should be given serious consideration in future urban development, transportation planning and environmental policies," principal investigator Sergey Grinshpun, a professor of environmental health, said in a new release from the university.

He noted that school-age children spend more than 30 percent of their day at school.

"For many years, our focus has been on homes when it comes to air pollution. School attendance may result in a large dose of inhaled traffic pollutants that -- until now -- have been completely overlooked," Grinshpun said.

New schools should be located well away from major highways, he suggested.

"Health risk can be mitigated through proper urban planning, but that doesn't erase the immediate risk to school-age children attending schools that are too close to highways right now," Grinshpun said. "Existing schools should be retrofitted with air filtration systems that will reduce students' exposure to traffic pollutants."

The study will be published in the September issue of the Journal of Environmental Planning and Management.

More information

The American Academy of Family Physicians has m
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
2. One-Third of Parents Lack Facts About Child Development
3. Nearly one-third of US parents dont know what to expect of infants
4. Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds
5. One-Third of Dementia Cases Laid to Small Blood Vessel Damage
6. Americans Guess One-Third of Professional Athletes on Performance Enhancing Drugs
7. One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines
8. Kaiser Permanente Study Shows One-Third of Women Have Overactive Bladder, Incontinence or Other Pelvic Floor Disorders
9. One-third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
10. One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC
11. AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Constraint-induced movement therapy (CIMT) is a po...ren with hemiplegic cerebral palsy, but more resea...w published in the November issue of Physical The...n Physical Therapy Association (APTA). The review,...ematic reviews, concluded that further research sh...
(Date:12/2/2009)... Revolutionary new cell phones that direct ...l be available in early 2010 from Aerius Internati...mber 2, 2009 -- Revolutionary new cell phones that...sers will be available in early 2010 from Aerius I...red with a Green Technology Award in wireless comm...
(Date:12/2/2009)... A team of Kendall Hunt authors earned the ...d at the recent National Association for Gifted Ch...ember 5-7, 2009. , Dubuqu...l Hunt authors earned the 2009 Gifted Child Quarte... Association for Gifted Children’s annual co...
(Date:12/2/2009)...HINGTON, Dec. 2 Pro-abo..., December 2 in their campaign against the U.S. Ho... Americans United for Life President and CEO Charm...the abortion lobby,s effort to expand taxpayer fun...h health care, the feminist groups and the abortio...
(Date:12/2/2009)...S ANGELES, Dec. 2 At a ...Tourism ministerial delegates came together to out...equired to give it the necessary thrust. Organized...edicaltourismassociation.com , the high-powered co...iscussed the opportunities and requests for assist...
Breaking Medicine News(10 mins):Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3
...A hospital in Chennai has created history by succe...ant in an eight-year-old Ugandan boy using the co...on of what the procedure would cost internationall...ht to the Apollo Specialty Hospital here. ...
...Three gene variants in the DNA of 486 AIDS patient...the HIV virus, according to research published Th... will lead to a vaccine that would boost the prote...mising, the scientists said in a study to appear i...
...A British woman will be aiming to raise awareness ...y when she sets out on a solo row across the Pacif...Roz Savage, 38, has already traversed the Atlantic... across the vast expanse of the Pacific. S...
...Madrid is the culinary melting pot of a country wh...rld by the New York Times, the author of a new boo...here is no real Madrid cooking but that's because ...novative cooking in Madrid). Rincon came u...
...Supermodel Petra Nemcova turned vegetarian to help...gave up meat and dairy products in February after ... "I read that if we fish the way we fish, ... star insisted that that she felt a 'strong connec...
...Burlesque star Dita Von Teese says that she often ... healthy hobby to be a voyeur. The estran...ur pornography has something to offer to almost ev... She insists that she is just like other people ...
Other Medicine News:Health News:Chennai Hospital Conducts Bone Marrow Transplantation Successfully 2Health News:Three Gene Variants Could Hold Key for HIV Vaccine: Study 2Health News:Briton Set for Pacific Solo Odyssey to Highlight Warming 2
(Date:12/2/2009)... , PLEASANTON, Calif., Dec. 2 /PRNewswire-Firs...nced today that the United States Food & Drug ...ed use for its licensed nucleic acid test, to scre...dividual donations. The test, called the cobas... system, is a qualitative, in-vitro test for the s...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-...r the "Company") (NYSE: SCR ), a leading pharmac...anufacturing, and marketing of branded,generic and...ted that its,subsidiary Jiangsu Yanshen Biological...s suspended production of all its products in orde...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewsw...cluding a late-breaking presentation on Tasigna...ic myeloid leukemia, demonstrate the strength of t... care of patients. ,, The new data, at the 51s...ing and Exposition, highlight the company,s curren...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Brain computer interface developed at Brown begins new clinical trial 8783 1Brain computer interface developed at Brown begins new clinical trial 8783 2Brain computer interface developed at Brown begins new clinical trial 8783 3Brain computer interface developed at Brown begins new clinical trial 8783 4Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 1Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 2Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 3Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 1Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 2
...nces announced,today, the initiation of a Phase 2 ...he treatment and management of acute infectious,mo...apeutics for the,treatment for this debilitating c...n-Barr virus (EBV), "Valomaciclovir has shown a b...ibition of viral replication of herpes zoster and ...
...gel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today a... PFE ), has begun a Phase 1 clinical trial of an,...kinase inhibitor, R343,for the treatment of allerg...Rigel,s clinical portfolio., Under the terms of t...will receive a $5 million milestone payment from P...
Other Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
Alloclassic Hip
Perfecta RS Stems
S-ROM Femoral Stems - XX-Long Length Stems 36mm Neck with 21mm Calcar Replacement + Lat Neck
S-ROM Femoral Stems - Long Length Stems Standard 36mm Neck
Medicine Products: